The trajectory of companies tied to flagship drugs like Viagra presents a challenging investment landscape . While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the expiry in key markets has introduced substantial risk . Investors are now grappling with the impact of lower-cost alternat